Search the Newsreel

Earnings Flash (PK) Park Hotels & Resorts Inc. Reports Q2 Revenue $680.0M, vs. FactSet Est of $660.1M

Park Hotels & Resorts Inc. (PK) reported its Q2 revenue at $680.0 million, surpassing FactSet's estimate of $660.1 million. The company's portfolio includes 34 hotels and resorts across the United States, operating through Core, consolidated Non-Core, and unconsolidated hotels segments. Recent analyst adjustments and …

Park Hotels & Resorts (NYSE: PK) raises 2026 guidance after Q2 gains

NPK International (NPKI) After Strong Q2 And Higher 2026 Outlook Faces An Undervalued Debate

Park Hotels & Resorts (NYSE:PK) Issues FY 2026 Earnings Guidance

Park Hotels & Resorts (PK) Earnings Date and Reports 2026 $PK

OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know

OPKO Health: Mazdutide And MDX-2201 Could Change Everything (NASDAQ:OPK)

Park Hotels & Resorts (PK) Q2 2026 Preview: EPS Est. $0.22, Reports August 7

Park Hotels & Resorts (PK) is set to report its Q2 2026 earnings on August 7, with analysts expecting an EPS of $0.22 and revenue of $658.3 million. This forecast suggests a significant improvement from a loss in Q2 2025, primarily due to margin …

Cocrystal Pharma Secures $5 Million Investment from OPKO Health as Norovirus Program Advances Toward Phase 1b Data

Cocrystal Pharma has secured a $5 million investment from longtime investor OPKO Health, increasing OPKO's stake in the company. This funding will support Cocrystal's norovirus program, particularly its lead candidate CDI-988, as it advances towards releasing topline data from its Phase 1b clinical trial …

Cocrystal Pharma (NASDAQ: COCP) secures $5M investment from OPKO Health

Cocrystal Pharma has secured a $5 million investment from longtime investor OPKO Health through a private placement of 5,474,053 common shares at $0.9134 per share. The biotech company plans to use these proceeds to advance its preclinical and clinical antiviral programs, including its lead …

OPKO Buys 5.47M Cocrystal Shares Ahead of Late-2026 Norovirus Data

OPKO Health has made a $5 million private placement in Cocrystal Pharma, purchasing 5,474,053 common shares at $0.9134 per share. This investment aims to support the advancement of Cocrystal's lead norovirus candidate, CDI-988, with topline Phase 1b data anticipated by the end of the …

Quantinno Capital Management LP Has $21.86 Million Stock Position in Park Hotels & Resorts Inc. $PK

How Do NPK International’s Raised 2026 Targets and Expansion Plans Recast Its Growth Story (NPKI)?

Park Hotels & Resorts (PK) Gains On Strong Momentum, Is The Stock Still Below Fair Value?

Park Hotels & Resorts (PK) has shown strong recent share price performance, with significant gains over the last 30 days to 3 years. Despite this momentum, Simply Wall St's analysis suggests the stock is undervalued by 22.3% with a fair value of $19.39 against …

OPKO Health (OPK) Is Up 14.1% After Narrower Q2 Loss and New 2026 Revenue Guidance – Has The Bull Case Changed?

OPKO Health (OPK) reported a significantly narrower Q2 net loss of US$8.42 million and issued new 2026 revenue guidance of US$560 million to US$585 million, leading to a 14.1% stock increase. The article explores whether this reduced loss and updated guidance change the investment …

OPKO Health: A Hold As Progress Continues (NASDAQ:OPK)

Enterprise value to EBIT forward of Park Hotels & Resorts Inc. – NYSE:PK

This article provides financial information for Park Hotels & Resorts Inc. (NYSE: PK), focusing on its enterprise value to EBIT forward. It includes general market data, company financials, and other related resources from TradingView. The content appears to be a stub or a data …

NPK International Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:NPKI) 2026-07-31

Key Points Interested in NPK International Inc.? Here are five stocks we like better. Strong second-quarter performance: Revenue rose 20% year over year to $82 million, while adjusted EBITDA increased 37% to $26 million, supported by record rental and service revenue and a 28% …

Opko Health, Inc. Revenue Breakdown – NASDAQ:OPK

Opko Health, Inc. (NASDAQ: OPK) generated $606.90 million in revenue last year, with its Diagnostics segment being the top performer at $370.27 million. The United States was the largest geographical contributor, accounting for $436.06 million of the revenue. These figures provide a breakdown of …

Park Hotels & Resorts Inc. Revenue Breakdown – NYSE:PK

This article provides a revenue breakdown for Park Hotels & Resorts Inc. (NYSE: PK). The company generated $2.54 billion USD last year, with its Core Hotels segment contributing the most at $2.01 billion USD. The United States was the primary geographic contributor to this …

Do NPK International’s (NPKI) Upgraded 2026 Targets Clarify Its Earnings Quality Story?

NPK International raises 2026 adjusted EBITDA outlook to $97M-$103M while keeping mid-2027 Louisiana expansion start-up date

Earnings Call Insights: NPK International Inc. (NPKI) Q2 2026 MANAGEMENT VIEW * Matthew Lanigan (President, CEO & Director) said the quarter showed “continued momentum in our core markets and the operating leverage inherent in our business model,” and highlighted “meaningful progress on our strategic …

Earnings Beat: OPKO Health, Inc. (NASDAQ:OPK) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

OPKO Health, Inc. recently reported a significant earnings beat, surpassing analyst revenue and statutory EPS forecasts. Following these results, analysts have raised their revenue and EPS estimates for the company's future performance, suggesting a more optimistic outlook. The revised forecasts indicate a positive sentiment …

OPKO Health FY2026 EPS Estimate Increased by HC Wainwright

HC Wainwright has increased its FY2026 EPS estimate for OPKO Health to a loss of $0.23 per share from $0.30, while maintaining a "Buy" rating. This upgrade follows OPKO's recent quarterly results, which surpassed expectations with a $0.01-per-share loss against an estimated $0.08 loss …

PPK Group Limited Revenue Breakdown – ASX:PPK

Is OPKO Health (OPK) A Bargain After Its Q2 Earnings And 52 Week High?

OPKO Health Number of Employees 2026 | Employee Count & Headcount Data

OPKO Health (NASDAQ: OPK) had approximately 2,275 employees worldwide as of March 2026, representing a 13.9% decline from 2023. Despite this decline, the company is actively hiring, with 129 active job postings in 2026, a 71.6% increase from the previous year. The workforce is …

BlackRock (NYSE: PK) discloses 14.7% ownership in Park Hotels & Resorts

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 14.7% beneficial ownership in Park Hotels & Resorts Inc. common stock, amounting to 29,586,347 shares. BlackRock holds sole voting power over 28,909,892 shares and sole dispositive power over all 29,586,347 shares, with no shared …

OPKO Health (NASDAQ:OPK) Reaches New 52-Week High - Here's Why

OPKO Health (NASDAQ:OPK) shares recently hit a new 52-week high after reporting second-quarter results that significantly beat expectations. The company narrowed its adjusted loss and saw revenue rise 4.3% year over year, leading management to raise its 2026 revenue outlook. Despite these positive developments …

Park Hotels & Resorts (PK) to Release Quarterly Earnings on Wednesday

OPKO Health gives back 17% after sharp post-earnings surge (OPK:NASDAQ)

OPK|OPKO Health Inc|Price:1.650|Chg%:+0.410

This article provides a comprehensive stock analysis of OPKO Health Inc (OPK), highlighting its healthy fundamentals, significant growth potential, and fair valuation within the Healthcare Providers & Services industry. It notes high institutional ownership and recent "Buy" ratings from analysts, with expectations for the …

Park Hotels & Resorts Is Maintained at In-Line by Evercore ISI Group

Evercore ISI Group has maintained its "In-Line" rating for Park Hotels & Resorts (NYSE: PK). The report does not detail the specific reasons for this rating.

OPKO Health (OPK) VP withholds 53,266 shares for taxes

OPKO Health's Executive VP-Administration, Steven D. Rubin, reported a tax-related share withholding on July 24, 2026. A total of 53,266 shares of common stock, valued at $1.22 per share, were withheld to cover tax obligations stemming from vested restricted stock units. Following this transaction, …

OPKO Health Stock Up as Q2 Earnings & Revenues Beat Estimates

OPKO Health reported a narrower-than-expected loss and higher revenues for Q2 2026, driven by strong growth in its Pharmaceuticals segment and exceeding analyst estimates. The company also raised its full-year 2026 revenue guidance. This positive performance is attributed to improved pharmaceutical revenues, including income …

Biopharmaceutical and Diagnostics Stock OPKO Health, Inc. (NASDAQ: OPK) Reaches 52 Week High on Second Quarter News

OPKO Health, Inc. (NASDAQ: OPK) saw its stock reach a new 52-week high after reporting strong second-quarter 2026 financial results and significant progress in its clinical programs. The company posted consolidated revenue of $163.5 million and a narrowed net loss of $8.4 million, with …